The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline.
There is enormous need for well-trained providers who are educated in treating opioid use disorder.
Investigators examined whether opioid overdose is more likely if a family member has a prescription. We review their findings.
Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.
The USPSTF finds that the current evidence is insufficient to recommend primary care-based interventions to prevent illicit drug use in children, adolescents, and young adults.
Participants with current moderate to severe chronic pain and opioid use were assessed for substance abuse problems.
The authors suggest that removing X-waiver requirements would allow healthcare providers to better assist patients with opioid use disorder.
Linkage to office-based buprenorphine treatment reduced illicit opioid use and increased days of buprenorphine treatment in patients discharged from a short-term detoxification program.
Marijuana use is risky for young people and pregnant women.
Investigators noted a significant increase in the odds of concurrent and subsequent marijuana use in adolescents and young adults who used e-cigarettes.